Category Archives: American Association for Cancer Research
Researcher who once tried to sue critics has another dozen papers retracted
A cancer researcher who went to court — unsuccessfully — claiming that commenters on PubPeer had cost him a new job has just lost another 12 papers. The twelve now-retracted papers by Fazlul Sarkar and colleagues — as well as another by Sarkar that is now subject to an editor’s note — all appeared in … Continue reading Researcher who once tried to sue critics has another dozen papers retracted
Cancer journals retract 10 papers, flag 8 more, and apologize for the delay
Five journals published by a prominent cancer research society have retracted a total of 10 papers — most of them by a former researcher at the MD Anderson Cancer Center in Houston. Nine of the 10 retractions share that researcher, Bharat Aggarwal, as an author. Aggarwal — who more than five years ago threatened to sue … Continue reading Cancer journals retract 10 papers, flag 8 more, and apologize for the delay
Nearly two years after a university asked for retractions, two journals have done nothing
How long should a retraction take? That’s a complex question, of course, depending on how long the alleged issues with a paper take to be investigated, whether authors — and their lawyers — fight tooth-and-nail against a retraction, and other factors. But once a university officially requests a retraction, how long should one take? The … Continue reading Nearly two years after a university asked for retractions, two journals have done nothing
Posted by in American Association for Cancer Research, cancer research
Early data on potential anti-cancer compound now in human trials was falsified, company admits
A pharmaceutical company has admitted that one of its former researchers falsified early data on a compound that’s designed to fight cancer, now in human trials. The data, published as an abstract in August 2015 in the journal Cancer Research, reported a therapeutic benefit of acalabrutinib in a mouse model of pancreatic cancer. The compound, […]
The post Early data on potential anti-cancer compound now in human trials was falsified, company admits appeared first on Retraction Watch.
“The article must be retracted:” Journal pulls prostate cancer study
A 2016 paper exploring the biology of prostate cancer has been retracted due to figure manipulation. According to the retraction notice, a reader contacted the journal Clinical Cancer Research in late 2016 with concerns that similar bands appeared multiple times in two images. The editors asked the paper’s corresponding author, Shahriar Koochekpour, about the issue […]
The post “The article must be retracted:” Journal pulls prostate cancer study appeared first on Retraction Watch.
Drip, drip: UCLA investigation finds more image duplications
Image duplications and unsupported data continue to plague a network of cancer researchers that includes the former vice chancellor for research at the University of California, Los Angeles, James Economou. On July 2, the editors at Cancer Research retracted a 2011 paper that Economou published as last author, saying it suffered from image duplication and […]
The post Drip, drip: UCLA investigation finds more image duplications appeared first on Retraction Watch.
Former UCLA vice-chancellor loses cancer paper for image manipulation
The former vice chancellor for research at the University of California, Los Angeles, has retracted a 2012 paper after an internal investigation found evidence of image manipulation. The journal Molecular Cancer Therapeutics received a letter about the problems with the paper from the UCLA Research Integrity Officer, and a retraction request from last author James Economou, also […]
The post Former UCLA vice-chancellor loses cancer paper for image manipulation appeared first on Retraction Watch.
A university asked for numerous retractions. Eight months later, three journals have done nothing.
When journals learn papers are problematic, how long does it take them to act? We recently had a chance to find out as part of our continuing coverage of the case of Anil Jaiswal at the University of Maryland, who’s retracted 15 papers (including two new ones we recently identified), and has transitioned out of […]
The post A university asked for numerous retractions. Eight months later, three journals have done nothing. appeared first on Retraction Watch.
Posted by in American Association for Cancer Research, biochem biophys research comm, cancer biology, cancer research, Chemico-Bio Interactions, clinical cancer research, company of biologists, duplication retractions, elsevier, FEBS J, free radical biology medicine, freely available, image manipulation, jbc retractions, journal of cell science, misconduct investigations, molecular cancer therapeutics, nature publishing group, oncogene (journal), society journal retractions, united states, wiley, wiley retractions
Cancer org bestows award on scientist under investigation
This month hasn’t been all bad for Carlo Croce. Despite issuing two corrections and being the subject of a lengthy New York Times article about how he’s dodged misconduct accusations for years (prompting his institution to re-open an investigation), Croce is now the recipient of a prestigious award from the American Association for Cancer Research. In a recent […]
The post Cancer org bestows award on scientist under investigation appeared first on Retraction Watch.
3rd retraction appears for fired Pfizer breast cancer researcher
Pfizer has retracted a paper by a former employee who was fired after the company discovered she had been doctoring data. The retraction, in Molecular Cancer Research, is the third of five papers Pfizer asked to retract, after an investigation discovered they contained duplicated images. The papers have been discussed on PubPeer, which is also […]
The post 3rd retraction appears for fired Pfizer breast cancer researcher appeared first on Retraction Watch.